Rapid-acting Insulin Admelog Solostar Insulin Lispro Injection

Admelog, an alternative to the common mealtime insulin Humalog, is available in disposable prefilled pens and vials and can be used in insulin pumps.

In 2017, Sanofia s Admelog became the first biosimilar fast-acting insulin in the US. Admelog (insulin lispro injection) is used to lower blood sugar levels for people with type 1 diabetes ages three and older and adults with type 2 diabetes.

As a biosimilar to the mealtime insulin Humalog (insulin lispro), Admelog works the same way as Humalog to provide glucose control a specifically, by reducing blood sugar spikes. Admelog is available in disposable prefilled pens and vials and can be used in insulin pumps. It is also approved in Europe under the name a Insulin lispro Sanofi.a

What is a biosimilar insulin?
Biosimilars have very similar structure and function to existing biologics (medications made in a natural, living system). This is sometimes also called a a follow ona product. Biosimilars undergo testing, are reviewed by the FDA, and are just as safe and effective as their brand name products.

As a biosimilar, Admelog has a very similar structure to Humalog and therefore acts very similar to Humalog. While the two drugs are not 100% identical, the differences are so small that they are not considered meaningful.